Analysis of endogenous LRP6 function reveals a novel feedback mechanism by which Wnt negatively regulates its receptor.

PubWeight™: 1.40‹?› | Rank: Top 5%

🔗 View Article (PMC 2168903)

Published in Mol Cell Biol on August 13, 2007

Authors

Zahid Khan1, Sapna Vijayakumar, Teresa Villanueva de la Torre, Sabrina Rotolo, Anna Bafico

Author Affiliations

1: Department of Oncological Sciences, The Mount Sinai School of Medicine, Box 1130, One Gustave L. Levy Place, New York, NY 10029, USA.

Articles citing this

Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell (2009) 18.31

Initiation of Wnt signaling: control of Wnt coreceptor Lrp6 phosphorylation/activation via frizzled, dishevelled and axin functions. Development (2007) 3.28

Canonical and noncanonical Wnts use a common mechanism to activate completely unrelated coreceptors. Genes Dev (2010) 2.28

Beta-catenin signaling, liver regeneration and hepatocellular cancer: sorting the good from the bad. Semin Cancer Biol (2010) 1.91

The Wnt receptor, Lrp5, is expressed by mouse mammary stem cells and is required to maintain the basal lineage. PLoS One (2009) 1.83

Palmitoylation and ubiquitination regulate exit of the Wnt signaling protein LRP6 from the endoplasmic reticulum. Proc Natl Acad Sci U S A (2008) 1.64

DKK1 antagonizes Wnt signaling without promotion of LRP6 internalization and degradation. J Biol Chem (2008) 1.44

Wnt-pathway activation in two molecular classes of hepatocellular carcinoma and experimental modulation by sorafenib. Clin Cancer Res (2012) 1.44

The way Wnt works: components and mechanism. Growth Factors (2012) 1.37

Wnt isoform-specific interactions with coreceptor specify inhibition or potentiation of signaling by LRP6 antibodies. PLoS One (2010) 1.34

High-frequency canonical Wnt activation in multiple sarcoma subtypes drives proliferation through a TCF/β-catenin target gene, CDC25A. Cancer Cell (2011) 1.22

Both LRP5 and LRP6 receptors are required to respond to physiological Wnt ligands in mammary epithelial cells and fibroblasts. J Biol Chem (2012) 1.14

Mutation in EGFP domain of LDL receptor-related protein 6 impairs cellular LDL clearance. Circ Res (2008) 1.08

Versican facilitates chondrocyte differentiation and regulates joint morphogenesis. J Biol Chem (2010) 1.05

Sequential activation and inactivation of Dishevelled in the Wnt/beta-catenin pathway by casein kinases. J Biol Chem (2011) 1.04

Identification of novel bone-specific molecular targets of binge alcohol and ibandronate by transcriptome analysis. Alcohol Clin Exp Res (2008) 1.00

Dkk1 stabilizes Wnt co-receptor LRP6: implication for Wnt ligand-induced LRP6 down-regulation. PLoS One (2010) 0.99

The first propeller domain of LRP6 regulates sensitivity to DKK1. Mol Biol Cell (2009) 0.90

Loss-of-function point mutations and two-furin domain derivatives provide insights about R-spondin2 structure and function. Cell Signal (2009) 0.90

Protein N-glycosylation in oral cancer: dysregulated cellular networks among DPAGT1, E-cadherin adhesion and canonical Wnt signaling. Glycobiology (2014) 0.88

Aberrant amplification of the crosstalk between canonical Wnt signaling and N-glycosylation gene DPAGT1 promotes oral cancer. Oral Oncol (2012) 0.86

Mapping the epistatic network underlying murine reproductive fatpad variation. Genetics (2010) 0.85

Aberrant activation of Wnt/β-catenin signaling drives proliferation of bone sarcoma cells. Oncotarget (2015) 0.85

LRP6 exerts non-canonical effects on Wnt signaling during neural tube closure. Hum Mol Genet (2013) 0.84

Coordinate regulation of N-glycosylation gene DPAGT1, canonical Wnt signaling and E-cadherin adhesion. J Cell Sci (2012) 0.83

Novel insights into Notum and glypicans regulation in colorectal cancer. Oncotarget (2015) 0.82

High-affinity Dkk1 receptor Kremen1 is internalized by clathrin-mediated endocytosis. PLoS One (2012) 0.78

Negative feedback regulation of Wnt signaling via N-linked fucosylation in zebrafish. Dev Biol (2014) 0.75

Downregulation of the Repressor Element 1-Silencing Transcription Factor (REST) Is Associated with Akt-mTOR and Wnt-β-Catenin Signaling in Prion Diseases Models. Front Mol Neurosci (2017) 0.75

Extracellular inhibitors can attenuate tumorigenic Wnt pathway activity in adenomatous polyposis coli mutants: Predictions of a validated mathematical model. PLoS One (2017) 0.75

Extracellular LDLR repeats modulate Wnt signaling activity by promoting LRP6 receptor endocytosis mediated by the Itch E3 ubiquitin ligase. Genes Cancer (2017) 0.75

Articles cited by this

Wnt/beta-catenin signaling in development and disease. Cell (2006) 30.09

Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science (1997) 24.61

Wnt signaling and cancer. Genes Dev (2000) 18.53

Cell signaling by receptor tyrosine kinases. Cell (2000) 18.16

Wnt signaling: a common theme in animal development. Genes Dev (1997) 12.94

WNT and beta-catenin signalling: diseases and therapies. Nat Rev Genet (2004) 10.38

Receptor downregulation and multivesicular-body sorting. Nat Rev Mol Cell Biol (2002) 10.12

Secreted antagonists of the Wnt signalling pathway. J Cell Sci (2003) 8.02

Distinct endocytic pathways regulate TGF-beta receptor signalling and turnover. Nat Cell Biol (2003) 7.74

LDL-receptor-related protein 6 is a receptor for Dickkopf proteins. Nature (2001) 7.44

A new member of the frizzled family from Drosophila functions as a Wingless receptor. Nature (1996) 7.04

LDL-receptor-related proteins in Wnt signal transduction. Nature (2000) 6.94

An LDL-receptor-related protein mediates Wnt signalling in mice. Nature (2000) 6.34

Wnt signaling: multiple pathways, multiple receptors, and multiple transcription factors. J Biol Chem (2006) 6.32

LDL receptor-related proteins 5 and 6 in Wnt/beta-catenin signaling: arrows point the way. Development (2004) 6.21

Head inducer Dickkopf-1 is a ligand for Wnt coreceptor LRP6. Curr Biol (2001) 5.95

A dual-kinase mechanism for Wnt co-receptor phosphorylation and activation. Nature (2005) 5.50

Low-density lipoprotein receptor-related protein-5 binds to Axin and regulates the canonical Wnt signaling pathway. Mol Cell (2001) 5.19

arrow encodes an LDL-receptor-related protein essential for Wingless signalling. Nature (2000) 5.13

Casein kinase 1 gamma couples Wnt receptor activation to cytoplasmic signal transduction. Nature (2005) 4.88

Clathrin- and non-clathrin-mediated endocytic regulation of cell signalling. Nat Rev Mol Cell Biol (2005) 4.48

Novel mechanism of Wnt signalling inhibition mediated by Dickkopf-1 interaction with LRP6/Arrow. Nat Cell Biol (2001) 4.38

A mechanism for Wnt coreceptor activation. Mol Cell (2004) 4.31

Wnt signaling in osteoblasts and bone diseases. Gene (2004) 3.72

Dishevelled 2 recruits beta-arrestin 2 to mediate Wnt5A-stimulated endocytosis of Frizzled 4. Science (2003) 3.52

An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells. Cancer Cell (2004) 3.30

Trafficking of the ErbB receptors and its influence on signaling. Exp Cell Res (2003) 2.90

Wnt signals across the plasma membrane to activate the beta-catenin pathway by forming oligomers containing its receptors, Frizzled and LRP. Development (2004) 2.84

R-spondin1 is a high affinity ligand for LRP6 and induces LRP6 phosphorylation and beta-catenin signaling. J Biol Chem (2007) 2.61

Caveolin is necessary for Wnt-3a-dependent internalization of LRP6 and accumulation of beta-catenin. Dev Cell (2006) 2.49

A critical role for endocytosis in Wnt signaling. BMC Cell Biol (2006) 2.09

Multiplicity of the interactions of Wnt proteins and their receptors. Cell Signal (2006) 2.01

cDNA cloning of the bovine low density lipoprotein receptor: feedback regulation of a receptor mRNA. Proc Natl Acad Sci U S A (1983) 1.98

Wnts as ligands: processing, secretion and reception. Oncogene (2006) 1.90

A novel mechanism for Wnt activation of canonical signaling through the LRP6 receptor. Mol Cell Biol (2003) 1.67

Chemokine receptor internalization and intracellular trafficking. Cytokine Growth Factor Rev (2005) 1.59

The mechanism of endogenous receptor activation functionally distinguishes prototype canonical and noncanonical Wnts. Mol Cell Biol (2005) 1.39

Characterization of Wnt-1 and Wnt-2 induced growth alterations and signaling pathways in NIH3T3 fibroblasts. Oncogene (1998) 1.36

Mechanism of glucocorticoid receptor down-regulation by glucocorticoids. J Biol Chem (1988) 1.23

Ligand-dependent down-regulation of stably transfected human glucocorticoid receptors is associated with the loss of functional glucocorticoid responsiveness. Mol Endocrinol (1992) 0.87

N-glycosylation is required for efficient secretion of a novel human secreted glycoprotein, hPAP21. FEBS Lett (2004) 0.84

Articles by these authors

Prostate cancer cells promote osteoblastic bone metastases through Wnts. Cancer Res (2005) 2.32

Canonical and noncanonical Wnts use a common mechanism to activate completely unrelated coreceptors. Genes Dev (2010) 2.28

The Wnt receptor, Lrp5, is expressed by mouse mammary stem cells and is required to maintain the basal lineage. PLoS One (2009) 1.83

A novel mechanism for Wnt activation of canonical signaling through the LRP6 receptor. Mol Cell Biol (2003) 1.67

Canonical Wnts function as potent regulators of osteogenesis by human mesenchymal stem cells. J Cell Biol (2009) 1.44

The mechanism of endogenous receptor activation functionally distinguishes prototype canonical and noncanonical Wnts. Mol Cell Biol (2005) 1.39

The human Frizzled 6 (HFz6) acts as a negative regulator of the canonical Wnt. beta-catenin signaling cascade. J Biol Chem (2004) 1.37

Impaired trafficking and activation of tumor necrosis factor-alpha-converting enzyme in cell mutants defective in protein ectodomain shedding. J Biol Chem (2003) 1.16

Functional interactions between anthrax toxin receptors and the WNT signalling protein LRP6. Cell Microbiol (2008) 1.06

The clinical application of autologous bioengineered skin based on a hyaluronic acid scaffold. Biomaterials (2008) 0.87

AKT and MAPK signaling in KGF-treated and UVB-exposed human epidermal cells. J Cell Physiol (2007) 0.85

Overexpression of the fibroblast growth factor receptor 2-IIIc in Kaposi's sarcoma. J Dermatol Sci (2008) 0.80

Modulation of the expression of the FGFR2-IIIb and FGFR2-IIIc molecules in dermatofibroma. J Dermatol Sci (2008) 0.79

Hair regeneration from transected follicles in duplicative surgery: rate of success and cell populations involved. Dermatol Surg (2009) 0.75